Evidence map›Paper›PMID 23985164›Full record

ArticleEuropean journal of medical research2013

Clinical significance of the uPA system in gastric cancer with peritoneal metastasis.

Youcheng Ding, Hui Zhang, Mingan Zhong, Zhuqing Zhou, Zhixiang Zhuang, Hua Yin, Xujing Wang, Zhenggang Zhu

Open access · goldAbstract read
In one paragraph

Article in European journal of medical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Youcheng DingDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Road II, Shanghai 200025, China. zhenggang_zhu132@hotmail.com.
Hui Zhang
Mingan Zhong
Zhuqing Zhou
Zhixiang Zhuang
Hua Yin
Xujing Wang
Zhenggang Zhu
Shanghai East Hospital · CNRuijin Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been demonstrated that urokinase-type plasminogen activator (uPA) is involved in tumor cell metastasis by degrading the extracellular matrix. However, there is little direct evidence of clinical uPA system expression in peritoneal metastatic tissues of gastric cancer. The objective of this study was to investigate uPA system expression in peritoneal tissues of peritoneal and nonperitoneal metastasis patients, and to explore the diagnostic value of the uPA system.

methodsExpressions of uPA, uPAR, and PAI-1 were measured by semi-quantitative RT-PCR and ELISA. uPA activity was detected using a uPA activity kit.

resultsThere was no significant difference in uPA, uPAR, and PAI-1 expression in two types of peritoneal tissue in seven patients with peritoneal metastasis. However, uPA, uPAR, and PAI-1 expressions in peritoneal metastatic lesions were significantly higher than those in normal peritoneal tissues of 24 nonperitoneal metastasis patients (P <0.05). Moreover, no statistical discrepancy of uPA activity was observed in various different tissues.

conclusionsThe expression of the uPA system positively correlates with peritoneal metastasis of gastric cancer. This expression difference in peritoneal or nonperitoneal metastasis patients may provide a reference for diagnosis of peritoneal metastasis.

Indexed as

AdultAgedAged, 80 and overCarcinoembryonic AntigenCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPeritoneal NeoplasmsPlasminogen Activator Inhibitor 1Receptors, Urokinase Plasminogen ActivatorRNA, MessengerStomach NeoplasmsUrokinase-Type Plasminogen ActivatorCarcinoembryonic AntigenPlasminogen Activator Inhibitor 1Receptors, Urokinase Plasminogen ActivatorRNA, MessengerUrokinase-Type Plasminogen Activator

Identifiers

PMID23985164
PMCPMC3766264
OpenAlexW2108222610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.